<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01899001</url>
  </required_header>
  <id_info>
    <org_study_id>818103</org_study_id>
    <nct_id>NCT01899001</nct_id>
  </id_info>
  <brief_title>Mood and Nutrition Interventions in Polycystic Ovary Syndrome</brief_title>
  <acronym>MANI-PCOS</acronym>
  <official_title>Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to help determine the best treatment plan for women with PCOS
      who are overweight or obese and experiencing significant symptoms of depression and anxiety.

      Specifically, the investigators are attempting to see if there is a difference between
      cognitive behavioral therapy in combination with nutritional counseling in improving mood
      symptoms, response to stress, and risk factors for heart disease compared to nutrition
      counseling alone. The investigators hypothesize that combined treatment with Cognitive
      Behavioral Therapy (CBT) and nutritional counseling will be more beneficial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will assess the impact of treatment of mood and associated anxiety disorders in
      conjunction with nutritional/exercise counseling in overweight/obese women with PCOS on
      cardiometabolic risk. The investigators hypothesize that women with PCOS will have greater
      benefit from dual intervention (psychological and nutritional/exercise counseling) for change
      in depressive symptoms and cardiometabolic risk reduction compared to nutritional/exercise
      counseling alone. In addition, the investigators hypothesize that psychological counseling
      may improve cardiometabolic risk by decreasing stress responses and stress associated markers
      of inflammation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess change in mood symptoms after Cognitive Behavioral Therapy (CBT) and nutritional/exercise counseling compared to nutritional/exercise counseling alone.</measure>
    <time_frame>Baseline, Week 8, Week 16</time_frame>
    <description>Changes in mood symptoms will be assessed using the CES-D, STAI, HRQOL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess change in cardio metabolic risk factors after Cognitive Behavioral Therapy (CBT) and nutritional/exercise counseling compared to nutritional/exercise counseling alone.</measure>
    <time_frame>Baseline, Week 8, Week 16</time_frame>
    <description>Changes in cardio metabolic risk factors will be assessed using clinical parameters (blood pressure, waist circumference, BMI) and serum parameters (lipid profile, fasting glucose, insulin, total testosterone, free testosterone, sex hormone binding globulin, Apo A1, Apo B, hsCRP, IL-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess change in perceived stress and stress response after Cognitive Behavioral Therapy (CBT) and nutritional/exercise counseling compared to nutritional/exercise counseling alone.</measure>
    <time_frame>Baseline, Week 8</time_frame>
    <description>Changes in perceived stress and stress response will be assessed using the PSS and cortisol response to the Trier Social Stress Test (TSST)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Polycystic Ovary Syndrome (PCOS)</condition>
  <arm_group>
    <arm_group_label>CBT and Nutrition Counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of Cognitive Behavioral Therapy (CBT) and 16 weeks of Nutrition Counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutrition Counseling</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>16 weeks of Nutrition Counseling alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Participants will receive weekly, 30 minute sessions with a CBT-trained clinical psychologist for the first 8 weeks. Briefly, the purpose of CBT is to treat mood and associated anxiety disorders by changing dysfunctional thoughts that lead to negative mood states and maladaptive behaviors. Through the use of Socratic questioning, the therapist challenges the patient to observe the relationship between thoughts and feelings and to question the underlying beliefs that perpetuate negative affect. Ultimately, patients learns to recognize maladaptive automatic thoughts and develop a more rational and balanced way of thinking about themselves and the world around them.</description>
    <arm_group_label>CBT and Nutrition Counseling</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutrition Counseling</intervention_name>
    <description>All women will receive nutrition/exercise counseling by a trained counselor. They will consume a self-selected diet of 1500-1800kcal/d of conventional foods based on the Food Guide Pyramid. Participants will also have an exercise goal that starts at 50 minutes per week and increases to 175 minutes per week. Sessions will teach standard weight loss skills, including self-monitoring, problem-solving, enlisting social support, and overcoming negative thoughts. Subjects will be asked to keep daily food intake and exercise logs which will be reviewed at the nutrition counseling sessions. These sessions will occur in person once weekly lasting on average 30 minutes for 16 sessions.</description>
    <arm_group_label>CBT and Nutrition Counseling</arm_group_label>
    <arm_group_label>Nutrition Counseling</arm_group_label>
    <other_name>Dietary Counseling</other_name>
    <other_name>Exercise Counseling</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Polycystic Ovary Syndrome (PCOS)

          -  Overweight or obese (BMI 27-50)

          -  Screen positive for symptoms of depression

        Exclusion Criteria:

          -  Smoking 5 or more cigarettes per day

          -  Severe depression/anxiety warranting immediate treatment

          -  Actively participating in a weight loss program

          -  Taking medications to control cholesterol or diabetes

          -  On hormonal therapy (must be discontinued to be eligible)

          -  Pregnancy or planning to become pregnant during the study period

          -  Inability to commute to Philadelphia for weekly study sessions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anuja Dokras, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn PCOS Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011 Jan;117(1):145-52. doi: 10.1097/AOG.0b013e318202b0a4. Review.</citation>
    <PMID>21173657</PMID>
  </reference>
  <reference>
    <citation>Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012 Jan;97(1):225-30.e2. doi: 10.1016/j.fertnstert.2011.10.022. Epub 2011 Nov 27. Review.</citation>
    <PMID>22127370</PMID>
  </reference>
  <reference>
    <citation>Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007 Jun;87(6):1369-76. Epub 2007 Mar 29.</citation>
    <PMID>17397839</PMID>
  </reference>
  <reference>
    <citation>Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May;95(5):2038-49. doi: 10.1210/jc.2009-2724. Epub 2010 Apr 7. Review.</citation>
    <PMID>20375205</PMID>
  </reference>
  <reference>
    <citation>Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001 Jun;86(6):2453-5.</citation>
    <PMID>11397838</PMID>
  </reference>
  <reference>
    <citation>Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004 May;89(5):2160-5.</citation>
    <PMID>15126536</PMID>
  </reference>
  <reference>
    <citation>Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009 May-Jun;15(3):297-307. doi: 10.1093/humupd/dmp006. Epub 2009 Mar 4. Review.</citation>
    <PMID>19261627</PMID>
  </reference>
  <reference>
    <citation>Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14. Epub 2007 Sep 11.</citation>
    <PMID>17848406</PMID>
  </reference>
  <reference>
    <citation>Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999 Apr 27;99(16):2192-217. Review.</citation>
    <PMID>10217662</PMID>
  </reference>
  <reference>
    <citation>Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52.</citation>
    <PMID>15364185</PMID>
  </reference>
  <reference>
    <citation>Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med. 2000 May 8;160(9):1261-8.</citation>
    <PMID>10809028</PMID>
  </reference>
  <reference>
    <citation>Rutledge T, Linke SE, Krantz DS, Johnson BD, Bittner V, Eastwood JA, Eteiba W, Pepine CJ, Vaccarino V, Francis J, Vido DA, Merz CN. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Psychosom Med. 2009 Nov;71(9):958-64. doi: 10.1097/PSY.0b013e3181bd6062. Epub 2009 Oct 15.</citation>
    <PMID>19834049</PMID>
  </reference>
  <reference>
    <citation>Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010 Jun 29;56(1):38-46. doi: 10.1016/j.jacc.2010.03.034.</citation>
    <PMID>20620715</PMID>
  </reference>
  <reference>
    <citation>Fagundes CP, Glaser R, Hwang BS, Malarkey WB, Kiecolt-Glaser JK. Depressive symptoms enhance stress-induced inflammatory responses. Brain Behav Immun. 2013 Jul;31:172-6. doi: 10.1016/j.bbi.2012.05.006. Epub 2012 May 22.</citation>
    <PMID>22634107</PMID>
  </reference>
  <reference>
    <citation>Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril. 2009 Jan;91(1):207-12. doi: 10.1016/j.fertnstert.2007.11.022. Epub 2008 Feb 4.</citation>
    <PMID>18249398</PMID>
  </reference>
  <reference>
    <citation>Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005 Aug;90(8):4650-8. Epub 2005 Jun 8. Review.</citation>
    <PMID>15944216</PMID>
  </reference>
  <reference>
    <citation>Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. 2009 Dec;92(6):1966-82. doi: 10.1016/j.fertnstert.2008.09.018. Epub 2008 Dec 4.</citation>
    <PMID>19062007</PMID>
  </reference>
  <reference>
    <citation>Wing RR, Epstein LH, Marcus MD, Kupfer DJ. Mood changes in behavioral weight loss programs. J Psychosom Res. 1984;28(3):189-96.</citation>
    <PMID>6545356</PMID>
  </reference>
  <reference>
    <citation>Galletly C, Moran L, Noakes M, Clifton P, Tomlinson L, Norman R. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome--a pilot study. Appetite. 2007 Nov;49(3):590-3. Epub 2007 Apr 4.</citation>
    <PMID>17509728</PMID>
  </reference>
  <reference>
    <citation>Linden M, Zubraegel D, Baer T, Franke U, Schlattmann P. Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study). Psychother Psychosom. 2005;74(1):36-42.</citation>
    <PMID>15627855</PMID>
  </reference>
  <reference>
    <citation>Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998 May;14(4):245-58.</citation>
    <PMID>9635069</PMID>
  </reference>
  <reference>
    <citation>Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif A. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998 Jun;83(6):1976-87.</citation>
    <PMID>9626128</PMID>
  </reference>
  <reference>
    <citation>Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96.</citation>
    <PMID>6668417</PMID>
  </reference>
  <reference>
    <citation>Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28(1-2):76-81.</citation>
    <PMID>8255414</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2013</study_first_posted>
  <last_update_submitted>November 22, 2016</last_update_submitted>
  <last_update_submitted_qc>November 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Polycystic Ovary Syndrome</keyword>
  <keyword>PCOS</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Exercise</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Therapy</keyword>
  <keyword>Mood symptoms</keyword>
  <keyword>Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

